Analyst Research

Report Title Price
Trading Report for (WAG). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
$58.00
Buy
WALGREEN CO (WAG) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Walgreen Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Thomson Reuters Stock Report - WALGREEN CO (WAG-N)
Provider: Thomson Reuters Stock Report
$25.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Walgreen Co And OptumRx Agree To Multi Year Provider Services Pharmacy Network Arrangement


Monday, 4 Jun 2012 09:00am EDT 

Walgreens announced an extended, multi-year agreement in which Walgreens will build on its strategic partnership with OptumRx, one of the pharmacy benefit managers in the United States. The agreement provides continued, long-term access to Walgreens pharmacy services at more than 7,800 locations nationwide for members of prescription drug benefit plans managed by OptumRx. 

Latest Developments for Walgreen Co

Latest Key Developments in Retail

Company Quote

Walgreen Co
(WAG.N)
49.61
0.775 +1.59%
17 May 2013